The pathology of the platelet‘s melatonin production in aspirin-induced asthma

H. Evsyukova (St. Petersburg, Russian Federation)

Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Evsyukova (St. Petersburg, Russian Federation). The pathology of the platelet‘s melatonin production in aspirin-induced asthma. Eur Respir J 2007; 30: Suppl. 51, 2214

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aspirin-induced asthma as the pathology of the platelet‘s melatonin production
Source: Eur Respir J 2006; 28: Suppl. 50, 236s
Year: 2006

Melatonin and aspirin-induced asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 6s
Year: 2002

Erdosteine affects eicosanoid production in asthma and COPD
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Aspirin-induced asthma (AIA) as the manifestation of low melatonin production and platelet's pathology
Source: Eur Respir J 2001; 18: Suppl. 33, 432s
Year: 2001

The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


The role of mast cells in allergic, non-allergic and aspirin-induced asthma and rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 589s
Year: 2005

Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007

Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010

Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma
Source: Eur Respir J 2004; 24: 226-230
Year: 2004



Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


The effects of capsaicin on airway inflammation in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 586s
Year: 2004

Omalizumab decreases IgE production in patients with severe allergic asthma
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012


Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 444s
Year: 2004

A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017




Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis
Source: Eur Respir J 2003; 22: Suppl. 45, 109s
Year: 2003

The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004

IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003

Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 433s
Year: 2006

The study of bronchospastic eicosanoids levels in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003